04.13.2019 Issue 167

Visit HealthEconomics.Com Subscribe to Newsletters  |  Contact Us  |  Forward to a Friend
Sponsored by:

This Week's HEOR Jobs Round-up
Job of the Week Latest Jobs from the Jobs Portal

 US Market Access Engagement
Manager/ Director

The US Market Access Engagement Manager/Director will be the most senior market access expert for VCLS in the US.

Senior Medical Writer

Senior Research Analyst (HEOR)

Medical Statistician

Senior Health Economics & Real-World Evidence (HE-RWE) Scientist

Senior Health Economics/Outcomes Researcher

Senior Health Economist (HTA and Market Access)

Head of Economic Modelling

Peeples, HealthCore-NERI's Siami Spotlight Changing
Clinical Trial Paradigm for Rare, Orphan Diseases

Survey Finds Big Push to Bolster Data Analytics Strategies

Report: Competition High for Data Scientists

MAPS Announces New Guidance Resource

Industry Spotlight

Conferences Webinars
Leading the Value Revolution
    April 15, Salt Lake City, Utah

16th Annual Pharmaceutical Compliance Congress
    April 16-18, Washington, D.C.

Economic Evaluation for Oncology
    April 23, York, England

Future of OCM and Advanced Payment Models in Oncology
    April 25, Chicago, Illinois

Big Data, RWD and RWE: What’s the Difference and How is it Changing the Research Landscape?
    April 15

New Drug Pricing Strategies for a Changing Global Market
    April 24

Beyond Drug Development: The Increasing Role of Real-World Data and Real-World Evidence in Medical Research
    April 25

Conference of the Week Webinar of the Week Job of the Week Link of the Week

Syndicated Reports White Papers
Review of Influence: The Institute for Clinical and Economic Review

Innovative Drugs: Mapping the Pricing and Reimbursement Landscape

Orphan Drugs: European Payer Perspectives

Do Payers Really Want Pay-for-Performance?

Payer Engagement: Benchmarking Team Structure and Activity

Benchmarking Market Access Strategies for High-Cost Drugs and Biologics

2018 Specialty Drug Trends

The Global Use of Medicine in 2019 and Outlook to 2023

Breaking Through the Hype of Real-World Evidence

Time to Market: Accelerating Market Access

Orphan Drugs in the United States

Charting Real World Data and Evidence – Activity and Capabilities (2018)

Special Thanks to Our Partners:
              Evidera    HealthCore    University of FL
      Xcenda    OM1    Parexel    Jefferson    Dymaxium    
      Precision Xtract    Pharmerit    eMax Health    Sciformix
       Evidence Partners     ICON